Back to Selection     Print       Date : 30 Sep 2026
Fund Summary
Baroda BNP Paribas Health and Wellness Fund (G)
[Equity: Sectoral]  
 
Fund Details
Fund Type Growth Launch Date 27-Jun-25
Corpus(Cr.) 487.00 Latest NAV 10.4462 As on 29-10-2026
Equity(%) 97.06 52 Week High 10.9082
Debt(%) 2.94 52 Week Low 8.9599
Others(%) 0.00 Exit Load For units in excess of 10% of the investment, 1% will be charged for redemption within 1 year
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 0.00
Scheme Benchmark BSE Healthcare TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Ankeet Pandya
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. The Scheme does not guarantee/indicate any returns.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 36.50%
Top 10 Holdings 58.36%
Top 25 Holdings 91.87%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Pharma & Biotech 73.65
Healthcare 19.83
Cash 2.94
Miscellaneous 2.68
Software & Services 0.9
 
 
 
 
 
Portfolio Metrics
PB Ratio 6.93
PE Ratio 44.64
 
Top 25 Holdings
Holdings Net Asset(%)
Sun Pharmaceutical Industries Ltd. 8.58
Torrent Pharmaceuticals Ltd. 7.88
Divis Laboratories Ltd. 7.82
Ipca Laboratories Ltd. 6.13
Laurus Labs Limited 6.09
Lupin Ltd 5.79
Apollo Hospitals Enterprises Ltd. 5.28
Fortis Healthcare Ltd 3.98
Dr. Lal Pathlabs Limited 3.47
Mankind Pharma Limited 3.34
Glenmark Pharmaceuticals ltd 3.11
Aurobindo Pharma Ltd. 3.09
AstraZeneca Pharma India Ltd. 2.79
Clearing Corporation of India Ltd 2.78
Abbott India Ltd. 2.50
Emcure Pharmaceuticals Limited 2.39
ACUTAAS CHEMICALS LIMITED 2.36
Zydus Lifesciences Limited 2.24
Max Financial Services Limited 2.21
Aster DM Healthcare Limited 2.15
Concord Biotech Limited 2.11
Ajanta Pharma Ltd. 1.56
Symbiotec Pharmalab Limited 1.47
Nephrocare Health Services Limited 1.42
Metropolis Healthcare Limited 1.33

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
-2.12% -2.63% 10.28% 6.92%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
1.01% -5.23% -4.33% -11.05%
 
Scheme Benchmark [NSE - Nifty Healthcare TRI]
-2.23% -2.98% 8.71% 8.99%
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
0.00% 0.00% 0.00% 0.00%
 
 
-2.07% 7.60% 6.59% 11.58%
 
 
6.75% 21.05% 14.18% 10.60%
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
Baroda BNP Paribas Health and Wellness Fund (G) 0.00% 0.0000 0.0000% 0.0000 0.0000
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
Baroda BNP Paribas Health and Wellness Fund (G) 0.0000% 0.0000 0.0000 0.0000 0.0000
 
Back to Selection